Clinical Trial

Comparison of Omeprazole vs Vonoprazon in Treatment of H Pylori Infection

Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated June 27, 2025 (before its estimated February 2026 completion). Its status may not reflect the trial's current state.
Summary
Current studies have primarily focused on comparing the advantages and disadvantages of P-CAB and PPI drugs, with little comparison between different P-CAB drugs or between regimens with varying drug combinations and treatment durations. This study aims to evaluate the clinical effectiveness of vonoprazan-based H. pylori eradication therapy and compare it to that of conventional PPI based therapy in clinical practice.
Trial Details
NCT Number NCT07040839
Lead Sponsor Rehman Medical Institute - RMI
Conditions H Pylori
Enrollment 128 participants
Start Date 2025-07
Primary Completion 2026-02 (estimated)
Study Completion 2026-02 (estimated)
Updated on ClinicalTrials.gov 2025-06-27